March 21, 2022 NeuroSense Shares Surge Over 400% As FDA Clears Initiating PK Study Of PrimeC Read More
December 13, 2021 NeuroSense initiates subject dosing in pharmacokinetics study of ALS asset Read More
December 8, 2021 NeuroSense Therapeutics Announces Pricing of $12 Million Initial Public Offering Read More